An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.
This study has been completed.
The Immune Response Corporation
First Posted: August 31, 2001
Last Update Posted: June 24, 2005
Information provided by:
NIH AIDS Clinical Trials Information Service
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|